PUTRAJAYA (Oct 24): Malaysia is expected to secure access to Covid-19 vaccine supply in the first quarter of next year.
The Health Ministry (MOH) along with the Science, Technology and Innovation Ministry (MOSTI) in a joint statement today said priority would be given to frontliners from the health and security sectors such as doctors, nurses, police as well as prison and immigration personnel.
“To date, MOH has been in contact with eight vaccine candidates which are now at the third phase of clinical trial,” said a statement issued following the first meeting of the Vaccine Supplies Access Guarantee Special Committee, yesterday.
MOSTI and MOH said the government was also concluding negotiations with COVAX, an international initiative led by the World Health Organisation (WHO) and partners to ensure access to Covid-19 vaccines, which has nine Covid-19 vaccine candidates under the Global Alliance for Vaccine and Immunisation (GAVI).
“The government will provide financial allocation for the vaccine purchase through the Finance Ministry’s Covid-19 Fund,” said the statement.
According to the statement, the special committee meeting co-chaired by Health Minister Datuk Seri Dr Adham Baba and Science, Technology and Innovation Minister Khairy Jamaluddin also agreed to form four sub-committees across various ministries and agencies according to specific tasks.
The committees are related to the National Vaccination Policy, Suitable Vaccine Selection, Logistics Registration, Vaccine Development, Financial and Procurement as well as Communications involving vaccine procurement.
“The government is committed in obtaining a decision immediately to get the vaccine, this is to ensure the country does not miss out in getting a vaccine which is approved and proven to be safe,” the statement said.
The special committee was formed to ensure the Covid-19 vaccine supply is obtained immediately with MOSTI and MOH acting as the main committee in planning, implementing and monitoring the overall strategy for the vaccine supply until the immunisation programme is carried out.
Covid Vaccine from Cansino may be an issue for both catholics and muslims as it uses human fetal cell lines during the development of the vaccines.
"Malaysian Catholics need to know which Covid-19 vaccines we’ll be using
Now, at least five of the 10 Covid-19 vaccine candidates, that have entered human trial, use one or both human FOETAL cell lines:
HEK-293, a kidney cell line widely taken from a baby girl who was aborted in the Netherlands in 1972 and later developed into a cell line in a lab in 1973; PER.C6, developed from retinal cells from an 18-week-old foetus aborted in the Netherlands in 1985 and later converted into a fetal cell line in 1995.
You hesitate because it is the AstraZeneca Oxford Covid-19 vaccine. And you know it is made using the HEK293 which comes from the cells of a foetus that was aborted in 1972 (more on HEK293 later). You being a Catholic know that this is not an acceptable way to make vaccines. Stilll, you would most probably say yes to the vaccine to save your little girl because there is no other option.
one of them is developed using HEK293 and it is the one developed by CANSINO Biologics"
"If the successfully developed COVID-19 vaccine uses either porcine or human FETAL TISSUE, or both, it would DELAY THE HALAL CONVERSION of the inoculation, with any halal certification body approached by a vaccine developer expected to be under serious scrutiny."
Puad tells PM to quit, claims Azmin and Hamzah blamed during emotional meet Umno supreme council member contends that Muhyiddin lost credibility after Agong rejected his advice.
Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.
In a filing with Bursa Malaysia today, Kanger said it has entered into a memorandum of understanding (MoU) with Zuellig Pharma, the largest vaccine distributor in Malaysia and in Asia, to facilitate the import, warehousing and distribution of Covid-19 vaccines in Malaysia.
Separately, Kanger announced that it has also entered into an MoU with K-Star to appoint the latter as the sales agent of Covid-19 vaccines for private clinics in Malaysia.
Look n see first, a Big group from Singapore r selling Glove stocks. They say we r brave US is droping....I will take their words. I rather be a coward than be a Hero
Bad news for vaccines! "The Lancet" issued an article: Top British scientists warned that "many or all" COVID-19 vaccine projects may fail, and the first generation "probably not perfect." In fact, members of the British Vaccine Working Group warned in an article published in The Lancet that a fully effective vaccine may never be developed, and that early versions of approved vaccines may not be suitable for everyone.
Sinopharm, Sinovac and CanSino....which is the best? I read CanSino approved to be tested on military personnel only but Sinopharm and Sinovax approved to test on public in Middle East, Brazil, Indonesia, etc.
Very impressive development within 2 short months as per their latest announcement. Key points to note: - 1) TO MARKET & DISTRIBUTE CANSINO'S VACCINE (Ad5-nCoV) IN MALAYSIA & ASEAN - Malaysia to be the regional fill and finish hub for CanSino to supply the vaccine to the region. *The current population of South-Eastern Asia is 670,784,959 as of Friday, October 30, 2020, based on the latest United Nations estimates. https://www.worldometers.info/world-population/south-eastern-asia-population/ Go figure out the impact of this huge market on Solutn's future earnings! 2) WORKING CAPITAL ALLOCATED - Solutn has set aside RM30 million for working capital and a sum between RM6 million and RM8 million for capital expenditure. A section of its head office in Bukit Jalil will be converted into a vaccine facility. 3) MOH HAS RESPONDED POSITIVELY - According to the Grp’s Deputy MD Dato’ Dr. Mohd Nazlee Kamal (formerly the CEO of Bioeconomy Corp from 2011 to 2016), "We are already in talks with the Ministry of Health and they have responded with very encouraging feedback on our initiatives. Solution is also preparing for the submission of relevant documents to the National Pharmaceutical Regulatory Agency for pre-registration.”
Solutn is definitely way ahead of the other contenders (ie HWGB and Bintai) in terms of coming out with an effective vaccine.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
hashimM88
40 posts
Posted by hashimM88 > 2020-10-24 15:38 | Report Abuse
https://www.thestar.com.my/news/nation/2020/10/24/covid-19-vaccine-expected-to-be-secured-in-first-quarter-next-year-priority-to-be-given-to-frontliners